Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis

Clinical and Experimental Metastasis

Volumn 24, Issue 5, 2007, Pages 353-362

  Marshall, Jean Claude ^a   Nantel, Andre ^b   Blanco, Paula ^a   Ash, Josee ^b   Cruess, Stephanie R ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Animal model; Circulating malignant cells; Metastasis; Uveal melanoma

Indexed keywords

RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CELL ISOLATION; CONTROLLED STUDY; DISSEMINATED CANCER; DNA MICROARRAY; EXPERIMENTAL RABBIT; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR XENOGRAFT; UVEA MELANOMA;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM TRANSPLANTATION; RABBITS; TRANSPLANTATION, HETEROLOGOUS; UVEAL NEOPLASMS;

EID: 34547225107     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9072-z     Document Type: Article

References (33)

1. Char DH (2001) Tumors of the eye and ocular adnexa. Atlas of clinical oncology, Hamilton Lewiston, B.C. Decker, NY; Sales and distribution, US., B.C. Decker. xiv, p 476
2. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM et al (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119(7):969-982
3. Singh AD, Topham A (2003) Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 110(5):962-965
4. Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM et al (2006) Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 47(9):3703-3707
5. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448-456
6. Lopez-Velasco R, Morilla-Grasa A, Saornil-Alvarez MA, Ordonez JL, Blanco G, Rabano G et al (2005) Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. Melanoma Res 15(1):29-37
7. Blanco G, Saornil AM, Domingo E, Diebold Y, Lopez R, Rabano G et al (2000) Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Curr Eye Res 21(3):740-747
8. Blanco PL, Marshall JC, Antecka E, Callejo SA, Souza Filho JP, Saraiva V et al (2005) Characterization of ocular and metastatic uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 46(12):4376-4382
9. Blanco PL, Caissie AL, Burnier MN Jr (2004) Experimental models of uveal melanoma. Can J Ophthalmol 39(4):441-447
10. Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205-7209
11. Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, Harbour JW (2006). Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 66(9):4602-4609
12. Diebold Y, Blanco G, Saornil MA, Fernandez N, Lazaro MC (1997) Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr Eye Res 16(5):487-495
13. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G et al (1995) Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 62(2):155-161
14. Marshall JC, Caissie AL, Callejo SA, Antecka E, Burnier MN Jr (2004) Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology 71(5):241-245
15. Marshall JC, Gordon KD, McCauley CS, de Souza Filho JP, Burnier MN (2006) The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res 16(6):537-541
16. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN (2006) Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye (in press)
17. Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M et al (1998) Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Invest 78(2):153-163
18. Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA et al (1999) Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 5(10):2698-2703
19. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820-827
20. Berube M, Talbot M, Collin C, Paquet-Bouchard C, Germain L, Guerin SL et al (2005) Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin. Int J Oncol 26(2):405-413
21. Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O et al (2005) Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 46(12):4372-4375
22. Girnita A, All-Ericsson C, Economou MA, Astrom K, Axelson M, Seregard S et al (2006) The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res 12(4):1383-1391
23. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799-806
24. Boissan M, Beurel E, Wendum D, Rey C, Lecluse Y, Housset C et al (2005) Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am J Pathol 167(3):869-877
25. Saraiva VS, Caissie AL, Segal L, Edelstein C, Burnier MN Jr (2005) Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 15(4):245-250
26. Ryazanov AG, Pavur KS, Dorovkov MV (1999) Alpha-kinases: a new class of protein kinases with a novel catalytic domain. Curr Biol 9(2):R43-R45
27. Versele M, Thorner J (2005) Some assembly required: yeast septins provide the instruction manual. Trends Cell Biol 15(8):414-424
28. Spiliotis ET, Kinoshita M, Nelson WJ (2005) A mitotic septin scaffold required for Mammalian chromosome congression and segregation. Science 307(5716):1781-1785
29. Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T et al (2005) Cisplatin resistance and transcription factors. Curr Med Chem Anticancer Agents 5(1):15-27
30. Jean S, Bideau C, Bellon L, Halimi G, De Meo M, Orsiere T et al (2001) The expression of genes induced in melanocytes by exposure to 365-nm UVA: study by cDNA arrays and real-time quantitative RT-PCR. Biochim Biophys Acta 1522(2):89-96
31. Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira WD, Hearing VJ (2005) MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem 280(14):14006-14016
32. Vaisanen A, Kallioinen M, von Dickhoff K, Laatikainen L, Hoyhtya M, Turpeenniemi-Hujanen T (1999) Matrix metalloproteinase-2 (MMP-2) immunoreactive protein-a new prognostic marker in uveal melanoma? J Pathol 188(1):56-62
33. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB (2005) Variates of survival in metastatic uveal melanoma. J Clin Oncol 23(31):8076-8080